BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Bordeaux Neurocampus - ECPv4.9.10//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Bordeaux Neurocampus
X-ORIGINAL-URL:https://www.bordeaux-neurocampus.fr/en/
X-WR-CALDESC:Events for Bordeaux Neurocampus
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260414
DTEND;VALUE=DATE:20260501
DTSTAMP:20260414T233928
CREATED:20260303T224414Z
LAST-MODIFIED:20260413T130833Z
UID:195189-1776124800-1777593599@www.bordeaux-neurocampus.fr
SUMMARY:Cajal lectures - Frontier in Neural Organoids Modelling
DESCRIPTION:Venue: CARF \n\nLectures are open to everyone \nTuesday 14 April – 9 am\nGiuseppe Testa (Human Technopole\, Italy )\nTowards in vitro epidemiology: brain organoids at the intersection of Precision Medicine and One-Health \nTuesday 14 April – 11 am \nOrly Reiner (Weizmann Institute\, Israel)\nAdvancing Neurodevelopmental Research: Developing Human Brain Organoid models to investigate brain malformations (Virtual talk). \nWednesday 15 April – 9 am \nPietro Michiardi (EURECOM\, France)\nFoundations of generative AI\, with applications to trajectory inference. \nWednesday 15 April – 11 am \nGiulio Franzese (EURECOM\, France)\nEstimation of Mutual Information using Diffusion Processes. \nSaturday 18 April – 9 am \nMichael Wells (University of California\, USA)\nTowards an atlas of human vulnerability using cell villages. \nSaturday 18 April – 11 am \nAlexej Abyzov (Mayo Clinic\, USA)\nPost-zygotic mutations: a universal tool for studying cellular ancestries and lineages in human cells. \nTuesday 21 April – 9 am \nFlora Vaccarino (Yale University\, USA)\nUnderstanding variations in brain patterning during development and disease. \nThursday 23 April – 11 am\n Carlo Colantuoni (Johns Hopkins Univ School of Medicine\, USA)\nTranscriptomic decomposition and projection approaches to explore the fidelity of neural organoid models. \nMonday 27 April – 9 am \nJason Stein (University of North Carolina at Chapel Hill\, USA)\nAssessing molecular and cellular gene by treatment interactions using a population of neural progenitors. \nThursday 30 April – 9 am \nSara Bizzotto (Institut Imagine\, France)\nBrain mosaicism: insights into development and disease. \nThursday 30 April – 11 am \nHelena Kilpinen (University of Helsinki\, Finland)\nGenetic background effects in iPSCs and their implications for disease modeling. \nThursday 30 April – 2 pm \nJuergen Knoblich (Institute of Molecular Biotechnology\, Austria)\nModelling human brain development and disease in stem cell derived 3D culture (Virtual talk) \n
URL:https://www.bordeaux-neurocampus.fr/en/event/cajal-lectures-frontier-in-neural-organoids-modelling/
CATEGORIES:Cajal Lectures,For scientists,home-event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20260421T170000
DTEND;TZID=Europe/Paris:20260421T183000
DTSTAMP:20260414T233928
CREATED:20260413T085919Z
LAST-MODIFIED:20260413T090607Z
UID:197458-1776790800-1776796200@www.bordeaux-neurocampus.fr
SUMMARY:PhilInBioMed Seminar - Kenneth Kendler
DESCRIPTION:Online \nZoom link:\nhttps://u-bordeaux-fr.zoom.us/j/82646859942?pwd=ExI9settc928hyn93lQvHJMKQ6MeSh.1 \n\nKenneth S. Kendler\nMD\nVIPBG Distinguished Professor\,\nDepartment of Psychiatry\,\nVirginia Commonwealth University (USA) \nTitle\nA Conversation about Major Themes in the Philosophy of Psychiatry \nResearch Description\nThe major focus of my research is in the genetics of psychiatric and substance abuse disorders. Two major methodologies are used in this research. The first involves large population based twin samples. In these twins\, we address the aggregate role of genetic and environmental factors. We seek to understand how these factors interact and correlate\, and how\, through development\, the vulnerability to psychiatric illness and drug abuse is expressed. I have focused my work with twin samples from Virginia – in particular the Virginia Adult Twin Study of Psychiatric and Substance Use Disorders – but also worked with twin samples from Norway\, Sweden and Holland. My work has focused on a wide range of disorders including major depression\, anxiety disorders\, eating disorders\, externalizing behaviors\, alcoholism\, and drug abuse. I have worked a lot toward understanding the genetic and environmental sources of comorbidity of psychiatric and substance use disorders. My work has recently focused on developmental models\, models examining the structure of genetic and environmental risk factors for DSM disorders examined at the criteria level and the sources of cross-generational transmission of risk to drug abuse and criminality. I have a new grant that will contribute to the understanding of the causes major depressive disorder\, the commonest psychiatric disorder and a leading cause of disability throughout the world. This research will improve our ability to diagnose depression from electronic health records\, generate insights into the genetic architecture of depression\, separating out specific from non-specific genetic risk factors\, and will identify\, from the analysis of exome sequencing data\, genes that are involved in the etiology of the disorder. The research will provide new insights into disease\, and well enable the development of more effective therapy. \nThe second major research strategy that I work with is molecular genetics. I am closely involved in molecular genetics studies of schizophrenia\, alcoholism\, major depression and nicotine dependence. We have used the strategies of linkage analysis\, candidate gene association analysis\, but most of the current focus now is on genome wide association and sequence data. I have recently been especially interested in polygene models as applied to GWAS data. I am the PI on an NIHM funded project that involves analysis of the CONVERGE study of major depression. We interviewed 12\,000 cases with recurrent depression in China and controls and have low-pass sequence on all subjects. I am also PI on the VCU Alcohol Research Center that focused on gene networks that impact on response to alcohol across multiple invertebrate and vertebrate species including man. I am PI on a grant collecting a large sample of severely ill cases with Alcohol Use Disorder from the US which\, together with other parallel efforts\, will identify key risk genes for this disorder which can\, in turn\, improve our understanding of its biological causes and open up new therapeutic opportunities. Another project will collect samples from 10\,000 South Korean women with recurrent major depressive disorder and 10\,000 matched controls. All subjects will be genotyped and the location of genetic risk factors identified in a genome-wide association analysis. The cohort will also provide detailed information about the likely environmental causes of depression\, and when combined with a similarly deeply phenotyped cohort from China\, will form a uniquely powerful resource for the discovery of genes involved in recurrent major depressive disorder. In addition to this I am working on a project that seeks to clarify the etiology of key internalizing psychiatric disorders and closely associated functional medical disorders by applying a range of methods from epidemiology\, genetic epidemiology and molecular genetics to the large informative population-based cohort in the Netherlands called Lifelines. We will attempt to understand the origins of the comorbidity between these disorders and how genes and environment contribute to their development. To meet these goals\, we will apply advanced statistical methods to a unique set of epidemiological and molecular genetic resources. Finally\, I have a large grant which will be collecting clinical information and DNA on 27\,500 cases with bipolar disorder and 16\,000 controls in the following sites in Taiwan\, South Korea\, Singapore\, India\, and Pakistan. Studying BP genetics in Asia is important to the world and the U.S.\, as Asia constitutes 57% of the world population\, and many underrepresented groups in the U.S.\, such as Native Americans and Hispanics\, descend in part from early Asian populations. The six countries in A-BIG-NET cover 40% of the Asian populations. This project will generate a BP-I genetic resource of 20\,900 case and 7\,200 controls with rich phenotypic information and genetic data from a novel technology combining low-pass whole genome (1xWGS) and deep exome sequencing (55xWES). \nI have an active ongoing interest in psychiatric nosology. I have been heavily involved in the developments of DSM-III-R and DSM-IV and chaired the Scientific Review Committee for DSM-5. I am vice-chair for the APA steering committee to revise DSM-5. Finally\, I have a developed interest in the interface between Psychiatry and Philosophy with several paper-writing projects on-going. \n
URL:https://www.bordeaux-neurocampus.fr/en/event/philinbiomed-seminar-kenneth-kendler/
CATEGORIES:For scientists,home-event,Impromptu seminar,Other events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20260421T180000
DTEND;TZID=Europe/Paris:20260421T200000
DTSTAMP:20260414T233928
CREATED:20260220T145223Z
LAST-MODIFIED:20260414T160401Z
UID:194651-1776794400-1776801600@www.bordeaux-neurocampus.fr
SUMMARY:Stimulation cérébrale profonde : pour quelles maladies\, avec quels enjeux ?
DESCRIPTION:Lieu : Amphi Ellul\, Université de Bordeaux\, 35 place Pey-Berland\, Bordeaux  \nÉgalement en visio \n\nAvec la stimulation cérébrale profonde (SCP) dans le traitement des mouvements anormaux et particulièrement de la maladie de Parkinson au cours des années 1980 et 1990\, une fenêtre s’est entrouverte sur une nouvelle forme de psychochirurgie. \n\nQuels sont aujourd’hui les usages de la stimulation cérébrale profonde ? Pour quelles maladies ? Avec quels impacts et pour quels enjeux ? \nLa diffusion du documentaire “Nos vies avec Parkinson” :\nEn introduction de cette conférence\, vous sera proposée la diffusion du documentaire “Nos vies avec Parkinson”\, réalisé par Joseph Coriat et Guillaume Leblond dans le cadre de l’émission “Enquête de santé”\, présentée par Marina Carrère d’Encausse avec Enora Malagré\, diffusée sur France 5 un mardi par mois. \n“Journaliste et auteur\, Joseph Coriat a été diagnostiqué alors qu’il n’avait que 38 ans. Avec son expérience de la maladie\, il part à la rencontre de malades de tous âges pour les questionner sur leurs vies avec Parkinson. Cathy\, Sylvie\, Valérie\, Guillaume\, Anthony et Bertrand sont les visages de la maladie. (…) Parkinson\, ce sont des symptômes et des traitements lourds\, mais c’est également la recherche qui progresse à grands pas et la neurochirurgie qui change la vie de certains malades. (…)” (source France TV pro) \nLa diffusion sera suivie d’une discussion sur les enjeux de la stimulation cérébrale profonde* avec :\nBernard BIOULAC\nDirecteur honoraire de l’ERENA site Aquitain\, directeur de l’ERENA Bordeaux de 2015 à 2021\, directeur adjoint de l’ERENA de 2018 à 2021\, professeur émérite à l’université de Bordeaux\, membre de l’académie nationale de médecine. \nDominique GUEHL\nNeurologue\, chef de service neurophysiologie clinique de l’enfant et de l’adulte\, Pôle neurosciences clinique du CHU de Bordeaux\, chercheur à l’Institut des Maladies Neuro-dégénératives\, CNRS\, Université de Bordeaux \nAlexandra FOUBERT-SAMIER\nNeurologue\, praticienne hospitalière\, cheffe adjointe du service de neurologie des maladies neurodégénératives\, CHU de Bordeaux\, coordinatrice du CENTRE EXPERT PARKINSON\, chercheuse INSERM\, Bordeaux Population Health Center\, Université de Bordeaux \nConférence gratuite\, ouverte à tous\, sur inscription : VOUS INSCRIRE \nEn savoir plus\n\nhttps://bordeaux.espace-ethique-na.fr/agenda_1039/egb26-conference-neurosciences-21-avril-2026_4448.html \n\n .  \n
URL:https://www.bordeaux-neurocampus.fr/en/event/stimulation-cerebrale-profonde-pour-quelles-maladies-avec-quels-enjeux/
CATEGORIES:Events for all,home-event
END:VEVENT
END:VCALENDAR